Literature DB >> 6941847

Chronic granulocytic leukemia in a horse.

G P Searcy, J P Orr.   

Abstract

A nine year old quarter horse exhibited progressive weight loss and inappetance over a 47 day period. There was clinical evidence of pleuritis and pneumonia substantiated by leukocytosis and elevated protein in pleural fluid. Over the entire period the horse was neutropenic and had circulating abnormal immature granulocytes and low numbers of blast cells. Anemia and thrombocytopenia progressively worsened. Bone marrow examination revealed very few mature granulocytes but large numbers of immature cells of the granulocytic series and marked megaloblastic transformation of erythroid cells. These findings were consistent with chronic granulocytic leukemia.

Entities:  

Mesh:

Year:  1981        PMID: 6941847      PMCID: PMC1790045     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  1 in total

1.  Myeloproliferative disease and abnormal erythrogenesis in the cat.

Authors:  J M Ward; C H Sodikoff; O W Schalm
Journal:  J Am Vet Med Assoc       Date:  1969-09-15       Impact factor: 1.936

  1 in total
  4 in total

1.  Acute myelomonocytic leukemia in a horse.

Authors:  D Bienzle; S L Hughson; W Vernau
Journal:  Can Vet J       Date:  1993-01       Impact factor: 1.008

2.  Acute myeloid leukemia with basophilic differentiation in a 3-year-old Standardbred gelding.

Authors:  Mary Catherine Furness; Emile Setlakwe; John Sallaway; Darren Wood; Jordan Fromstein; Luis G Arroyo
Journal:  Can Vet J       Date:  2016-10       Impact factor: 1.008

Review 3.  Hematopoietic neoplasias in horses: myeloproliferative and lymphoproliferative disorders.

Authors:  Ana Muñoz; Cristina Riber; Pablo Trigo; Francisco Castejón
Journal:  J Equine Sci       Date:  2010-01-19

Review 4.  A review of current knowledge of myeloproliferative disorders in the horse.

Authors:  Katy Satué; Juan Carlos Gardon; Ana Muñoz
Journal:  Acta Vet Scand       Date:  2021-02-23       Impact factor: 1.695

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.